Guidance on Unanticipated Problems (UPs) and Adverse Events (AEs) Bertha delanda IRB Training Specialist Research Compliance Office March 2010

Similar documents
Guidance on Unanticipated Problems (UPs) and Adverse Events (AEs) Bertha delanda IRB Training Specialist Research Compliance Office March 2010

Unanticipated Problems and Adverse Events

ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014

PHONE SCRIPTS, QUESTIONNAIRES AND WAIVERS OF DOCUMENTATION. Bertha delanda, CIP IRB Training Specialist January 2012

Understanding Adverse Events

Adverse Events- Love them, hate them, report them!

NCI CIRB Independent Model studies is described herein.

Manual for Expedited Reporting of Adverse Events to DAIDS Version 2.0 January 2010

Adverse Experience Reporting

WELCOME TO ONLINE TRAINING FOR CLINICAL RESEARCH COORDINATORS

SAE håndtering i protokol CC MM-001

DEMOGRAPHICS PHYSICAL ATTRIBUTES VITAL SIGNS. Protocol: ABC-123 SCREENING. Subject ID. Subject Initials. Visit Date: / / [ YYYY/MM/DD]

GENERAL INFORMATION. Adverse Event (AE) Definition (ICH GUIDELINES E6 FOR GCP 1.2):

Serious Adverse Event (SAE) Form Clinical Trials

Subject experienced tachycardia and atrial fibrillation while engaged in a study in the Human Studies Facility

Safety Manual: DAD Trial

OHRP Guidance on the Involvement of Prisoners in Research

Serious Adverse Event (SAE) Form Clinical Trials

Developing a Detection and Reporting System for Adverse Events. Deborah Hilgenberg Family Health International

This SOP applies to all IRB administrative staff, members and investigators. IRB members, administrative staff and investigators.

Protecting Human Subjects In Social-Behavioral-Educational Research:

Serious Adverse Event

RESEARCH INVOLVING PRISONERS

PHARMACOVIGILANCE GLOSSARY

NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN

Safety Assessment in Clinical Trials and Beyond

8.0 ADVERSE EVENT HANDLING

Adverse Event Reporting. Good Clinical Practice

1. What is your role in the AAHRPP accreditation process?

SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES

OHRP - Guidance on Research Involving Coded Private Information or Biological Specimens

Chapter 8: Safety, Adverse Events and Endpoints

Guidance on Returning Research Results to Subjects

Florida State University Policy 7-IRB-26

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Research That Must Be Reviewed by the IRB

WARNING LETTER. Ref: 09-HFD

1. Comply with the NCI CIRB s requirements and directives;

Reporting to the IRB Part 2

Conducting Research Involving Medical Imaging

ADVERSE EVENT REPORTING. Catherine Dillon, CCRP

NIH StrokeNet Network Standard Operating Procedure

Stopping rules for FIM trials

Navigating the Regulatory Requirements of Pediatric Research Nathan Lee, CIP Vice Chair, Schulman IRB

EXEMPT RESEARCH. Investigators should contact the IRB Office if there are questions about whether an amendment consists

Guidance - IDE Early/Expanded Access for Devices

If the HPTN 082 protocol is amended in the future, this Letter of Amendment will be incorporated into the next version.

COLUMBIA UNIVERSITY INSTITUTIONAL REVIEW BOARD GUIDANCE ON ELECTRONIC INFORMED CONSENT

IRB FREQUENTLY ASKED QUESTIONS. 1. Who must apply for human subjects review through the IRB (Institutional Research Board)?

ASSIGNED TREATMENT ARM

Safety Monitoring: The Patient Perspective. Kevin Weinfurt, PhD Kathryn Flynn, PhD

Adverse events following Immunisation Common and Uncommon. Dr Anna Clarke National Immunisation Office September

Adverse Events Following Immunisation. Castlebar, Nov. 8, 2013 Kevin Connolly

For a copy of slides please

The Complaint Department: How IRBs Handle Complaints, Questions and Concerns from Study Participants

QA Program Evaluation Research Tool CF-195, Effective

Adverse Events Monitoring (aka Pharmacovigilance)

Inspections, Compliance, Enforcement, and Criminal Investigations

Revised August 28, 2018

Understanding Mental Health Preadmission Screening and Resident Review (PASRR) and Form Valerie Krueger Mental Health PASRR Specialist

INSTITUTIONAL REVIEW BOARD (IRB) PROCESS AND GUIDELINES FOR CONDUCTING RESEARCH AT ORANGE COAST COLLEGE

Research & Development. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Enrolling Non-English Speaking Participants in Clinical Research: Regulatory and Practical Considerations Michele Russell-Einhorn, JD

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See United States Package Insert (USPI)

SUBJECT: SJMHS Institutional Review Board(s): Vulnerable Populations - Research Involving Prisoners

IRB Approval From: 3/8/2010 To: 10/28/2010

Inspections, Compliance, Enforcement, and Criminal Investigations

FormsNet Adverse Event Form

Goal of site data management 12/2/2009. Ultimate goal: reliable and valid clinical trial to improve health

LONG-TERM INVESTIGATIVE FOLLOW-UP IN TRIALNET (LIFT) (Protocol TN-16)

Access to Experimental Therapies / FDA Expanded Access Programs

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care

FDA issues final guidance on benefit-risk factors to consider in medical device product availability, compliance, and enforcement decisions

Research Involving Human Subjects: Ethics, Process, and Guidance for Streamlining IRB Review

AFDO Conference June 9, Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide

Outcomes & Opportunities through Collaborating in Clinical Trials

International Research and the IRB: What you need to know before you go

IRB review of device studies

Serious Adverse Event Report Form (CTIMP)

Addressing Evolving CHMP Guidance of Phase I Study Designs

NIDA Rationale Clean 1 09/17/06

IRB Review Points to Consider September 2016

Biomarker classification: a philosophical introduction.

Investigator s Handbook for the Protection of Human Participants in Research Institutional Review Board Revised February 23, 2017

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

Stigma and Bipolar Disorder

Protection of Research Subjects: The IRB Process

COMMON RULE 2019 IMPLEMENTATION DATE: JANUARY 21, 2019

AN INVESTIGATOR S GUIDE TO RESEARCH WITH HUMAN PARTICIPANTS

Adverse Events Following. Kevin Connolly Waterford, Aug. 25, 2016

Inspections, Compliance, Enforcement, and Criminal Investigations

IRB policy and procedures 1. Institutional Review Board: Revised Policy and Procedures Elmhurst College

MedDRA Coding and Versioning

(Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives)

Department of the Navy Human Research Protection Program

CORPORATE. Work-Fit INJURY SOLUTIONS. Helping Workers Get Better And Stay Better

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE

IRB Reviewer Worksheet for Expedited Reviews

REGIS UNIVERSITY POLICIES AND PROCEDURES FOR THE REVIEW OF RESEARCH INVOLVING HUMAN SUBJECTS

FDA issues long-awaited final guidance on when a device modification requires a new 510(k)

Letter of Amendment # 3 to:

Transcription:

Guidance on Unanticipated Problems (UPs) and Adverse Events (AEs) Bertha delanda IRB Training Specialist Research Compliance Office March 2010

OUTLINE - AE (adverse event) - SAE (serious adverse event) - UP (unanticipated problem) - Unexpected - Related - Harmful - How does an AE become a UP? - Resources Research Compliance Office 2

Definitions AE any untoward or unfavorable medical occurrence in a human subject, temporally associated with a research study, whether or not it is related to the study Can encompass both psychological and physical harms Are not promptly reported to the IRB OHRP Guidance on Reviewing and Reporting UPs Involving Risks to Subjects or Others and Adverse Events Research Compliance Office 3

Definition SAE Serious Adverse Event SAE is an AE (untoward or unfavorable medical occurrence in a subject) that: 1) Results in death 2) Is life-threatening 3) Results in hospitalization (or prolongation of existing stay) 4) Results in a persistent or significant disability/incapacity 5) Results in a congenital abnormality/defect 6) May jeopardize subject health, and requires surgery/medical intervention to prevent other 5 criteria Research Compliance Office 4

OHRP Consideration OHRP considers some SAEs and AEs important events because they may: suggest that the research places subjects or others at a greater risk of harm than what was previously known warrant changes in the protocol, ICF procedures/documents Research Compliance Office 5

OHRP Consideration SAEs/AEs are submitted during the continuing review process but modifications to the protocol or the ICF can be submitted at any time Research Compliance Office 6

OHRP Definition UPs Any incident, experience, or outcome that meets ALL of the following criteria: 1) unexpected (in terms of nature, severity, specificity or frequency) 2) related or possibly related to participation in a study 3) places subject or others at a greater risk of harm* than was previously recognized * including physical, social, economic or psychological harm Research Compliance Office 7

General Relationship Between AEs/UPs SAEs A = Adverse Events that are not Unanticipated Problems B= AE s that are UPs C= Unanticipated Problems that are NOT Adverse Events Under 45 CFR 46: Do not report A; Report B and C

UPs 45 CFR 46.103(a) and 45 CFR 46.103(b)(5) Unanticipated problems involving risks to subjects or to others Are promptly reported to the IRB within 5 days of the PD discovery if death/lifethreatening situation occurs within 10 for all other UPs Initially determined to be UPs by monitoring entity, sponsor or PD IRB makes the final UP determination Research Compliance Office 9

Unexpected Example: Informed consent states that participants will have ECG pads put on various sites on the face and neck. Leland comes down with a rash at the pad sites. Unexpected? Yes; rash was not expected Research Compliance Office 10

Related Leland comes down with a rash before participating in a study but after consenting. Related? No; he had the rash before the study was conducted. Related : there is a reasonable possibility that the adverse event may have been caused by the procedures involved in the research Research Compliance Office 11

Harmful The informed consent states that you may receive a minor rash within a few hour of using the pads. The rash was so severe, Leland was hospitalized and was unable to go to work because it turned out he was allergic to the gel used for the study. Harmful? Yes; it placed Leland at physical and economic risk (in terms of lost wages) Research Compliance Office 12

How does an AE become a UP? Leland has a mood swing because of the questions he was subjected to, which was mentioned in the ICF as a possible reaction. But after a few weeks, his mood swing becomes a depression. Harmful Related now also Unexpected 13 Research Compliance Office

GUI-P13 45 CFR 46.103(b)(5) Resources Guidance On Reviewing and Reporting Unanticipated Problems http://www.hhs.gov/ohrp/policy/advevntguid.htm FDA Guidance: http://www.fda.gov/downloads/regulatoryinformation/gui dances/ucm127346.pdf